HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Luo Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2023Imbalance of Vaginal Microbiota and Immunity: Two Main Accomplices of Cervical Cancer in Chinese Women.
6/2020The efficacy and safety of cold atmospheric plasma as a novel therapy for diabetic wound in vitro and in vivo.
8/2011Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Luo Research Topics

Disease

55Neoplasms (Cancer)
05/2024 - 01/2006
18Vesicular Stomatitis
10/2022 - 02/2004
16Neoplasm Metastasis (Metastasis)
01/2023 - 02/2010
15Inflammation (Inflammations)
01/2023 - 10/2004
14Breast Neoplasms (Breast Cancer)
01/2023 - 01/2009
14Infections
12/2022 - 02/2003
8Human Influenza (Influenza)
10/2022 - 07/2003
7Carcinogenesis
02/2024 - 01/2009
7Stomach Neoplasms (Stomach Cancer)
02/2024 - 03/2015
7Hepatic Encephalopathy
01/2023 - 11/2011
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2023 - 03/2010
7Urinary Bladder Neoplasms (Bladder Cancer)
05/2021 - 04/2013
6Virus Diseases (Viral Diseases)
03/2024 - 03/2011
6Tuberculosis (Tuberculoses)
01/2023 - 03/2004
6Scoliosis
03/2022 - 02/2017
6Fibrosis (Cirrhosis)
03/2021 - 06/2010
5Glioblastoma (Glioblastoma Multiforme)
01/2024 - 01/2015
5Starvation
11/2022 - 05/2010
5Heart Failure
12/2021 - 07/2005
5Cardiovascular Diseases (Cardiovascular Disease)
03/2021 - 01/2012
5Necrosis
06/2020 - 01/2012
5Reperfusion Injury
01/2019 - 11/2014
4Hepatocellular Carcinoma (Hepatoma)
05/2024 - 08/2010
4Glioma (Gliomas)
01/2024 - 01/2017
4Hemorrhage
10/2023 - 12/2010
4Wounds and Injuries (Trauma)
08/2023 - 06/2012
4Cholangiocarcinoma
11/2022 - 01/2021
4Liver Neoplasms (Liver Cancer)
01/2022 - 08/2010
4Essential Hypertension
01/2017 - 01/2013
3Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2023 - 01/2019
3Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2021
3Klatskin Tumor
11/2022 - 01/2022
3Rabies (Hydrophobia)
10/2022 - 01/2017
3Epilepsy (Aura)
01/2022 - 01/2016
3Renal Insufficiency (Renal Failure)
01/2022 - 01/2015
3Lymphatic Metastasis
08/2021 - 09/2011
3Hypoxia (Hypoxemia)
05/2021 - 01/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 08/2011
3Prostatic Neoplasms (Prostate Cancer)
01/2021 - 05/2017
3Congenital Abnormalities (Deformity)
12/2018 - 02/2017
3Hypertension (High Blood Pressure)
11/2018 - 03/2014
3Kyphosis
12/2017 - 07/2017
3Ischemia
06/2016 - 03/2010
2Disease Resistance
04/2024 - 06/2023
2Colonic Neoplasms (Colon Cancer)
03/2024 - 11/2023
2Squamous Intraepithelial Lesions
01/2024 - 01/2022

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
06/2023 - 07/2004
17RNA (Ribonucleic Acid)IBA
04/2023 - 02/2004
9Long Noncoding RNAIBA
01/2024 - 04/2013
8Biomarkers (Surrogate Marker)IBA
01/2023 - 08/2010
8Messenger RNA (mRNA)IBA
01/2022 - 02/2004
5VaccinesIBA
01/2022 - 07/2012
5MicroRNAs (MicroRNA)IBA
01/2021 - 12/2014
5AmmoniaIBA
12/2015 - 11/2011
5NucleoproteinsIBA
05/2010 - 02/2004
4Interleukin-6 (Interleukin 6)IBA
01/2023 - 12/2012
4salicylhydroxamic acid (SHAM)IBA
11/2022 - 01/2022
4Nucleocapsid ProteinsIBA
10/2022 - 05/2006
4Indicators and Reagents (Reagents)IBA
01/2022 - 09/2007
4CurcuminIBA
12/2020 - 01/2016
4Phosphotransferases (Kinase)IBA
01/2020 - 12/2007
4CytokinesIBA
01/2020 - 01/2012
4Focal Adhesion Protein-Tyrosine KinasesIBA
01/2020 - 01/2009
4Viral RNAIBA
01/2019 - 04/2013
4HomocysteineIBA
01/2017 - 08/2012
4EnzymesIBA
04/2015 - 01/2009
3Transcription Factors (Transcription Factor)IBA
12/2023 - 12/2017
3LipopolysaccharidesIBA
12/2023 - 01/2020
3Cadherins (E-Cadherin)IBA
11/2023 - 06/2013
3Anti-Bacterial Agents (Antibiotics)IBA
10/2023 - 03/2017
3Lactulose (Duphalac)FDA LinkGeneric
01/2023 - 11/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2023 - 02/2005
3Circular RNAIBA
01/2023 - 04/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 08/2011
3Particulate MatterIBA
12/2022 - 12/2018
3Saline SolutionIBA
11/2022 - 06/2010
3SuspensionsIBA
11/2022 - 01/2022
3Glycoproteins (Glycoprotein)IBA
10/2022 - 01/2015
3NitrogenIBA
10/2022 - 01/2020
3Peptides (Polypeptides)IBA
01/2022 - 01/2012
3Carbon MonoxideIBA
01/2021 - 01/2016
3Hemoglobins (Hemoglobin)IBA
01/2019 - 11/2014
3AntigensIBA
01/2018 - 09/2007
3AntibodiesIBA
01/2018 - 08/2013
3Interleukin-8 (Interleukin 8)IBA
12/2017 - 02/2010
3fasudil (AT 877)IBA
04/2016 - 01/2015
2InterferonsIBA
05/2024 - 01/2024
2LigandsIBA
05/2024 - 01/2020
2Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2024 - 02/2023
2Cyclin-Dependent Kinase 5IBA
02/2024 - 03/2015
2Competitive Endogenous RNAIBA
01/2024 - 01/2023

Therapy/Procedure

22Therapeutics
10/2023 - 12/2007
9Radiotherapy
03/2023 - 12/2010
6Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2024 - 11/2014
6Pedicle Screws
08/2019 - 02/2017
5Length of Stay
10/2023 - 12/2016
4Immunotherapy
01/2022 - 02/2009
3Transplantation
11/2023 - 01/2009
3Drug Therapy (Chemotherapy)
10/2023 - 01/2017
3Ligation
01/2023 - 09/2019